Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Computer-assisted therapy

07.05.2010
More targeted drug development thanks to systems biology – scientists at the SBMC 2010 in Freiburg explain how this works

Systems biology has finally come of age. Evidence for this is the third Conference on Systems Biology of Mammalian Cells (SBMC), which will take place on June 3-5, 2010 at the Concert Hall Freiburg (Konzerthaus) under the auspices of Prof. Dr. Annette Schavan, German Federal Minister of Education and Research. HepatoSys/Virtual Liver, the network for systems biology of the liver, will host the conference and the Federal Ministry of Education and Research (BMBF) has provided funding.

For three days experts from all over the world will have the opportunity to exchange knowledge in the field of systems-biological analysis of processes in mammalian cells. But the focus will not only be on the newest technologies and revolutionary concepts: scientists will also present how medicine and pharmaceutical research already benefit from systems biology today – in particular, from the development of new and reliable drugs.

A model to support decision-making
Systems biology investigates biological processes at the system level. It takes into account that all activities in a cell, an organ and even in a whole body are linked dynamically with one another. To illustrate these comprehensive networks, systems biology combines quantitative methods from the field of molecular biology with tools and methodologies from mathematics, computer sciences and systems sciences.

Medical-pharmaceutical research benefits above all from the systems-biological analysis of mammalian cells: simulations enable a better understanding of the dynamics of the complex disease promoting mechanisms and facilitate the exploration and development of more targeted therapies. The impact of drugs, too, can be simulated with the help of mathematical models, as they provide information on how an active pharmaceutical substance spreads within the body, how fast it metabolizes and, against this background, how it should be dosed. "However, it becomes really exciting at the point when you take the whole to the next higher level and start making decisions with the help of models regarding which pharmaceutical substances should be investigated further and studied, for instance, in clinical trials", Jörg Lippert of Systems Biology & Computational Solutions Bayer Technology Services GmbH in Leverkusen explains. Lippert’s team develops such simulations within the scope of HepatoSys/Virtual Liver.

The computer simplifies the assessment
Before scientists test a pharmaceutical substance in a clinical study, they have already done intensive research on the substance and its activity profile for many years. "Dozens of scientists are involved in this process, they produce unbelievable amounts of data and write reports on thousands of experiments", Lippert says. This provides the basis for experts to decide whether or not to continue further development of a pharmaceutical candidate. In the traditional approach, the basis for this kind of decision-making is years of experience, medicinal chemistry precedent and our understanding of biology. "No one can overlook and evaluate the diversity of scientific data in all its consequences. That is why the computer is an important tool," Lippert says. Skillfully used, systems biology models accumulate the information emerging from years of research and help the decision-makers to interpret it. Thus, with the help of simulations it is possible to predict how effective a candidate pharmaceutical may be, i.e. how many patients are likely ultimately benefit from it. Conversely, the simulations also illustrate the probability of side effects, even for rare and exceptional cases, which in a clinical study might not even be taken into consideration. “In this way, systems-biological models can help to make clinical studies more focused and reliable, reducing time and costs," Lippert summarizes.
Better medicine – especially for children
These models are especially important when it comes to children. According to current EU law and US-American regulations, pharmaceutical firms seeking approval for new medications must also always demonstrate how they plan to check the suitability of a drug for the treatment of children. However, this is especially difficult, as the Bayer researcher explains: "Children are not simply little people, but they differ in their body functions and tissue composition clearly from adults – and these things change when children’s bodies grow and develop." Moreover, certain clinical studies – in which for example, the dosage and tolerability of a pharmaceutical substance is tested on healthy individuals – are prohibited for children for ethical reasons. Systems-biological models help here: They forecast the effect of a pharmaceutical substance on children in different stages of development and so make it possible to evaluate whether and under which conditions a drug will show the expected effect on these little patients.
A solid foundation via basic research and the promotion of young scientists
"The applications in drug development are important results for systems biology. They show clearly that we are on the right path", says Jens Timmer, scientific speaker of the competence network HepatoSys/ and coordinator of the systems biology conference SBMC 2010. Still, he warns against overhasty euphoria: "During the next years, basic researchers from our field must do a lot of work so that systems biology remains on a solid foundation."

Against this background and in cooperation with the BMBF, the MTZ foundation from Erkrath near Dusseldorf promotes the young scientific generation in the field of systems biology. For the second time, three young scientists will be honored during the conference for their outstanding doctoral theses with the MTZ Award for medically oriented systems biology worth a combined total of 5,000 Euros.

The presentation will take place on Friday, June 4, 2010 at 2 pm.
On Saturday, June 5th at 11:45 am Jörg Lippert will speak about the application of systems-biological models to drug development.

Journalists are warmly invited to take part at the conference.

About the SBMC
The third systems biology conference "Conference on Systems Biology of Mammalian Cells (SBMC 2010) will take place on June 3-5, 2010 in Freiburg. It is organized by HepatoSys/Virtual Liver, the German network on systems biology of liver. HepatoSys was initiated in 2004 by the Federal Ministry of Education and Research (BMBF) – for the research of the intracellular processes in liver cells. Since April, 2010 the succession project Virtual Liver aims at understanding these processes at the next higher level: based on the results of HepatoSys, the scientists involved in Virtual Liver have started to examine processes in cell organization up to the whole organ.

Sabine Trunz | idw
Further information:
http://www.sbmc2010.de

More articles from Life Sciences:

nachricht Kidney tumor: Genetic trigger discovered
18.06.2018 | Julius-Maximilians-Universität Würzburg

nachricht New type of photosynthesis discovered
18.06.2018 | Imperial College London

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Novel method for investigating pore geometry in rocks

18.06.2018 | Earth Sciences

Diamond watch components

18.06.2018 | Process Engineering

New type of photosynthesis discovered

18.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>